NSCLC (NON-SMALL CELL LUNG CANCER)

Clinical trials for NSCLC (NON-SMALL CELL LUNG CANCER) explained in plain language.

Never miss a new study

Get alerted when new NSCLC (NON-SMALL CELL LUNG CANCER) trials appear

Sign up with your email to follow new studies for NSCLC (NON-SMALL CELL LUNG CANCER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 22 Not yet recruiting 7 Not yet finished but already full! 2 Completed 1

New combo therapy aims to boost lung cancer fight before and after surgery

Disease control Completed

This study tested if adding a newer immunotherapy drug (MEDI4736) to standard chemotherapy could better control a specific type of lung cancer (stage IIIA). The treatment was given both before surgery (to shrink the tumor) and after surgery (to prevent it from coming back). The g…

Matched conditions: NSCLC (NON-SMALL CELL LUNG CANCER)

Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control

Last updated Mar 16, 2026 15:27 UTC

NSCLC (NON-SMALL CELL LUNG CANCER)

Get alerted when new NSCLC (NON-SMALL CELL LUNG CANCER) trials appear

New combo therapy aims to boost lung cancer fight before and after surgery